Novartis Oncology Financial Analyst Salaries in Newark, NJ | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Financial Analyst Salaries in Newark, NJ

The average Novartis Oncology Financial Analyst in Newark, NJ earns an estimated $87,617 annually, which includes an estimated base salary of $78,828 with a $8,789 bonus. Novartis Oncology's Financial Analyst compensation is $207 more than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology in Newark, NJ can range from $54,000 - $150,000.

In Newark, NJ, The Finance Department at Novartis Oncology earns $13,966 more on average than the Operations Department.

Last updated 3 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$87,617
Average Compensation
$78,828
avg. base
$8,789
avg. bonus

Financial Analyst Salaries at Novartis Oncology

In Newark, NJ, Financial Analysts earn $3,908 more than Financial Analysts, and $6,335 less than Senior Accountants.

Accounting Manager
$119k*
Business Analyst
$102k*
Senior Accountant
$94k*
Financial Analyst
$84k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Newark, NJ, The Finance Department averages $13,966 more than the Operations Department, and $22,265 less than the HR Department

HR
$107,269 Avg. total comp.
+$22k
Finance
$85,004 Avg. total comp.
Operations
$71,038 Avg. total comp.
-$14k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Novartis Oncology Rate Their Compensation

The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company